NCT06253260

Analgesic Efficacy of Sequential Rapid Versus Slow Intrathecal Injection Of Dexmedetomidine Followed by of Hyperbaric Bupivacaine in Inguinal Hernia Repair Surgery

Name: Clinical Trial NCT06253260
Creator: Cairo University
Keywords: Postoperative Pain, Analgesic Efficacy of Sequential Rapid Intrathecal Injection Of Dexmedetomidine Followed by Slow Injection of Hyperbaric Bupivacaine Injection in Patients Undergoing Unilateral Inguinal Hernia Repair, drug, clinical trial, Egypt

Analgesic Efficacy of Sequential Rapid Intrathecal Injection Of Dexmedetomidine Followed by Slow Injection of Hyperbaric Bupivacaine Versus Sequential Slow Injection of Both Drugs in Patients Undergoing Unilateral Inguinal Hernia Repair Surgery

Cairo University·ClinicalTrials.gov·drugRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Postoperative Pain
Drug/Device/Intervention: Analgesic Efficacy of Sequential Rapid Intrathecal Injection Of Dexmedetomidine Followed by Slow Injection of Hyperbaric Bupivacaine Injection in Patients Undergoing Unilateral Inguinal Hernia Repair
Study type: Interventional
Intervention type: drug

Sponsor & location

Primary sponsor: Cairo University
Location: Cairo,Cairo, Egypt

Timeline & enrollment

Phase: N/A
Start date: Feb 15, 2024
End date: May 20, 2024
Enrollment: 50 participants

Primary outcome

Duration of postoperative analgesia

Summary

Analgesic Efficacy of Sequential Rapid Intrathecal Injection Of Dexmedetomidine Followed by Slow Injection of Hyperbaric Bupivacaine Versus Sequential Slow Injection of Both Drugs in Patients Undergoing Unilateral Inguinal Hernia Repair Surgery

ICD-10 classifications

Acute painPostoperative intestinal obstructionPain, unspecifiedDuring surgical operationDuring surgical operation

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06253260
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06253260 through Pure Global AI's free database. This phase not specified trial is sponsored by Cairo University and is currently Recruiting. The study focuses on Postoperative Pain. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.